Narrative review / 2013
Hibiscus sabdariffa tea or extracts significantly lowered blood pressure and improved lipid profiles in randomized clinical trials.
This review evaluated animal and human studies on Hibiscus sabdariffa (HS) for treating hypertension and hyperlipidemia. In randomized controlled trials, daily consumption of HS tea or extract significantly lowered systolic and diastolic blood pressure in adults with pre to moderate hypertension and type 2 diabetes, performing as well as Captopril but less effectively than Lisinopril. Furthermore, over half of the RCTs indicated daily HS intake favorably influenced lipid profiles by reducing total cholesterol, LDL-C, and triglycerides, and increasing HDL-C. The authors conclude that while HS is promising, more high-quality animal and human studies are required.
- Study type
- Comprehensive narrative review of animal and human studies
- Who was studied
- Adults with pre to moderate essential hypertension and type 2 diabetes
- What was measured
- Systolic and diastolic blood pressure, lipid profiles, and toxicity markers
THE PAPER
Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.
Hopkins AL, Lamm MG, Funk JL, Ritenbaugh C. Fitoterapia, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.